Market Overview

Covance Reports Significant Cost Initiatives


Goldman Sachs has published a research report on Covance, Inc. (NYSE: CVD) after the company reported 3Q EPS directly in-line with Goldman Sachs and Consensus.

In the report, Goldman Sachs writes "CVD reported adjusted 3Q EPS of $0.50 (which excluded ~$0.01-$0.02 from 2Q cost actions), versus GS/consensus at $0.50. As was widely anticipated, CVD announced several cost-cutting initiatives including the reduction of toxicology capacity by closing the facility in Vienna, VA. The company anticipates a contribution of at least $25 million to operating income in 2011 (net of costs of $35-$40 million) from this closure and other cost reduction measures. In addition, CVD provided more detail around the recently announced 10-yr exclusive deal with Sanofi and now expects earnings contribution from the deal in 2011 of $0.20+. Not to be overlooked, the core businesses struggled this quarter where we saw further margin erosion in both segments on a year-over-year and sequentially basis. While the cost actions are substantial and will no doubt help to offset weakness in underlying business, we still think long-term sustainable share performance remains connected to improving fundamentals particularly within early-development."

Goldman Sachs maintains its Neutral rating and $46 price target.

Covance's conference call is today at 9:00am (888) 569-5033 passcode: 4350056.

Covance, Inc. closed yesterday at $47.26.

Posted-In: covance Goldman SachsAnalyst Color Analyst Ratings


Related Articles (CVD)

View Comments and Join the Discussion!

Latest Ratings

RPAYCantor FitzgeraldMaintains18.0
CMSCredit SuisseDowngrades
PBCTStephens & Co.Maintains15.5
TTECCowen & Co.Initiates Coverage On50.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at